Patent Assignment
Reel/Frame 068869/0278
Security Interest
Recorded: 2024-10-10
Pages: 6
Assignee
PREMIER RESEARCH INTERNATIONAL, LLC
3800 PARAMOUNT PARKWAY, #400, MORRISVILLE, NORTH CAROLINA, 27560
Covered Properties
(27)
High Penetration Prodrug Compositions and Pharmaceutical Composition Thereof for Treatment of Pulmonary Conditions
Application:
18/400,716 →
Publication:
US 2024/0226084
Topical Administration of 2-(Diethylamino)Ethyl 2-(4-Isobutylphenyl)Proprionate for Treatment of Diseases
Application:
18/251,336 →
Publication:
US 2024/0024273
High Penetration Prodrug Compositions of Prostaglandins and Related Compounds
Application:
18/097,486 →
Publication:
US 2023/0174476
High Penetration Composition and Uses Thereof
Application:
17/493,321 →
Publication:
US 2022/0096370
High Penetration Prodrug Compositions of Mustards and Mustard-Related Compounds
Application:
18/049,041 →
Publication:
US 2023/0097823
High Penetration Prodrug Compositions of Antimicrobials and Antimicrobial-Related Compounds
Application:
18/051,060 →
Publication:
US 2023/0130980
High Penetration Prodrug Compositions of Retinoids and Retinoid-Related Compounds
Application:
18/488,616 →
Publication:
US 2024/0156770
Method for Improving the Stability of a Pharmaceutical Composition Comprising a High Penetration Drug, and the Pharmaceutical Composition Obtained Therefrom
Application:
17/906,637 →
Publication:
US 2023/0157952
High Penetration Compositions and Their Applications
High Penetration Prodrug Compositions of Mustards and Mustard-Related Compounds
High Penetration Prodrug Compositions of Antimicrobials and Antimicrobial-Related Compounds
High Penetration Prodrug Compositions of Antimicrobials and Antimicrobial-Related Compounds
High Penetration Compositions and Uses Thereof
High Penetration Composition and Uses Thereof
High Penetration Prodrug Compositions of 1H-Imidazo[4,5-C]Quinolin-4-Amines and 1H-Imidazo[4,5-C]Quinolin-4-Amine-Related Compounds and Uses Thereof
High Penetration Prodrug Compositions of Retinoids and Retinoids-Related Compounds
High Penetration Prodrug Compositions of Peptides and Peptide-Related Compounds
Pro-Drugs of Nsaias with Very High Skin and Membranes Penetration Rates and Their New Medicinal Uses
High Penetration Prodrug Compositions of Prostaglandins and Related Compounds
Novel High Penetration Drugs and Their Compositions Thereof for Treatment of Parkinson Diseases
Novel High Penetration Drugs and Their Compositions Thereof for Treatment of Parkinson Diseases
Novel High Penetration Drugs and Their Compositions Thereof for Treatment of Parkinson Diseases
High Penetration Prodrug Compositions and Pharmaceutical Composition Thereof for Treatment of Pulmonary Conditions
High Penetration Prodrug Compositions and Pharmaceutical Compoisiton Thereof for Treatment of Pulmonary Conditions
High Penetration Prodrug Compositions of Peptides and Peptide-Related Compounds
High Penetration Prodrug Compositions of 1H-Imidazo[4,5-C]Quinolin-4-Amines and 1H-Imidazo[4,5-C]Quinolin-4-Amine-Related Compounds
High Penetration Prodrug Compositions of Retinoids and Retinoid-Related Compounds
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 28, 2016
From: YU, CHONGXI; XU, LINA
To: TECHFIELDS PHARMA CO., LTD.
Reel/Frame 037605/0771 →
Assignment of Assignor's Interest
Jan 28, 2016
From: XU, LINA; CHEN, YUHUA; YAN, BINBING YAN; TU, SHIGIAN
To: TECHFIELDS PHARMA CO., LTD.
Reel/Frame 037606/0178 →
Assignment of Assignor's Interest
Jan 28, 2016
From: YU, CHONGXI
To: TECHFIELDS PHARMA CO., LTD
Reel/Frame 037605/0947 →
Assignment of Assignor's Interest
Jun 16, 2022
From: YU, CHONGXI; XU, LINA; CHEN, YUHUA; YAN, BINBING
To: TECHFIELDS PHARMA CO., LTD.
Reel/Frame 060223/0611 →
Assignment of Assignor's Interest
Aug 31, 2022
From: YU, CHONGXI; XU, LINA
To: TECHFIELDS PHARMA CO., LTD.
Reel/Frame 060953/0030 →
Assignment of Assignor's Interest
Sep 19, 2022
From: YU, CHONGXI; XU, LINA
To: TECHFIELDS INC.
Reel/Frame 061463/0017 →
Assignment of Assignor's Interest
Jan 27, 2023
From: YU, CHONGXI; XU, LINA
To: TECHFIELDS PHARMA CO., LTD.
Reel/Frame 062509/0110 →